These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29496022)

  • 21. Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.
    Hartwell EE; Moallem NR; Courtney KE; Glasner-Edwards S; Ray LA
    J Addict Med; 2016; 10(6):395-401. PubMed ID: 27504928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine-associated cardiomyopathy.
    Won S; Hong RA; Shohet RV; Seto TB; Parikh NI
    Clin Cardiol; 2013 Dec; 36(12):737-42. PubMed ID: 24037954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples.
    Mau MK; Asao K; Efird J; Saito E; Ratner R; Hafi M; Seto T
    Vasc Health Risk Manag; 2009; 5(1):45-52. PubMed ID: 19436660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of Methamphetamine Use and the Time Lag to Methamphetamine Dependence.
    Yimsaard P; Maes MM; Verachai V; Kalayasiri R
    J Addict Med; 2018; 12(2):92-98. PubMed ID: 29176447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.
    Swor DE; Maas MB; Walia SS; Bissig DP; Liotta EM; Naidech AM; Ng KL
    Neurology; 2019 Jul; 93(1):e1-e7. PubMed ID: 31142634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.
    Saloner R; Paolillo EW; Umlauf A; Moore DJ; Heaton RK; Grant I; Cherner M;
    J Int Neuropsychol Soc; 2019 Sep; 25(8):787-799. PubMed ID: 31179969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern and related factors of cognitive impairment among chronic methamphetamine users.
    Wang TY; Fan TT; Bao YP; Li XD; Liang CM; Wang RJ; Ma J; Han Y; Meng SQ; Wu P; Shi J; Lu L
    Am J Addict; 2017 Mar; 26(2):145-151. PubMed ID: 28177556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term use of methamphetamine disrupts the menstrual cycles and hypothalamic-pituitary-ovarian axis.
    Shen WW; Zhang YS; Li LH; Liu Y; Huang XN; Chen LH; Zhou W
    J Addict Med; 2014; 8(3):183-8. PubMed ID: 24695019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.
    Beadell NC; Thompson EM; Delashaw JB; Cetas JS
    J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine-associated cardiomyopathy: an addiction medicine perspective.
    Somma V; Osekowski M; Paratz E; Bonomo Y
    Intern Med J; 2023 Jan; 53(1):21-26. PubMed ID: 36693638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
    Callaghan RC; Cunningham JK; Verdichevski M; Sykes J; Jaffer SR; Kish SJ
    Drug Alcohol Depend; 2012 Oct; 125(3):290-4. PubMed ID: 22503689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction.
    Reddy PK; Chau E; Patel SV; Yang K; Ng TM; Elkayam U
    Am J Cardiol; 2021 Sep; 154():86-91. PubMed ID: 34233837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.
    Anglin MD; Urada D; Brecht ML; Hawken A; Rawson R; Longshore D
    J Psychoactive Drugs; 2007 Nov; Suppl 4():367-81. PubMed ID: 18284103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.